Serology test achieves 99.9% sensitivity and 99.5% specificity for SARS CoV-2; ProMIS proprietary peptide antigens to detect neutralizing antibodies in next development phase TORONTO and CAMBRIDGE, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback